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Sexual Dimorphism of Myointimal Proliferation
After Balloon Injury of Rat Carotid Artery is
Estrogen Dependent
Basic Fibroblast Growth Factor has Potent
Selective Effects on Collagen Gene Expression
by Human Vascular Smooth Muscle Cells
J. Geoffrey Pickering, lawrence H. Chow, Carol M. Ford. Robarts Research Institute
and University Hospital, London, Canada
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Basic fibroblast growth factor (bFGF) is a smooth muscle cell (SMC) mito-
gen known to playa role in the early response of the vessel wall to balloon
injury. During this initial stage, remodeling of the extracellular matrix (ECM),
including collagen. is necessary for cell proliferation, migration and lesion
expansion. We therefore determined the effect of bFGF on fibrillar collagen
gene expression by human vascular SMCs.
SMCs, cultivated from internal mammary artery, were serum-deprived and
incubated with bFGF (50 nglml) or vehicle. Collagen synthesis rate was de-
termined by labeling cultures with [3H]proline, separating proteins byelec-
trophoresis, and visualizing and quantifying bands by fluorography and laser
densitometry, respectively. This revealed a significant, net decrease in col-
lagen synthesis induced by bFGF. To determine the mechanism of this re-
sponse, the effect of bFGF on collagen mRNA was determined by North-
ern blot analysis using probes specific for a-chains of collagen types I, III,
and V, accounting for the major and minor fibrillar collagens found in human
atherosclerotic plaque. Cell proliferation was assessed by probing for his-
tone 3.2. Despite a consistent increase in SMC proliferation. bFGF reduced
expression of 0'1 (I) collagen mRNA by upto 90%. In contrast, bFGF increased
expression of 0'1(111) and a2(V) collagen mRNA by approximately 20%. Be-
cause type III and V collagen fibers are finer than type I, the divergent results
may reflect a shift to a less mature collagen lattice induced by bFGF.
Conclusion: Total fibrillar collagen synthesis by human SMCs is reduced
by bFGF, due to a potent selective inhibition of type I collagen expression.
This effect of bFGF on the ECM may be a prerequisite for SMC accumulation
and lesion formation following balloon angioplasty.
Shi-Juan Chen, Yiu-Fai Chen, Suzanne Oparil. Vascular Biology and Hypertension
Program. University ofAlabama at Birmingham, Birmingham, AL
Atherosclerotic vascular disease progresses more slowly in females with
functional ovaries than in males. Balloon injury of the rodent carotid artery is
widely used as a model for the early injury phase of atherosclerosis. The cur-
rent study tested whether female Sprague-Dawley rats (SD) have a reduced
(compared to males) vascular growth response to balloon injury and whether
this response is estrogen dependent. 10 wk old d' and ~ SD rats were ei-
ther gonadectomized or studied intact. Gonadectomized rats of both sexes
were implanted with (1) 15 mm (empty), (2) 10 mm (filled with 17-,8 estradiol
[E]) or (3) 15 mm (filled with testosterone [Tl) silastic capsules 3 days before
balloon injury of the carotid artery. Two wks later, rats were perfused with
10% formalin at 120 mmHg and carotid arteries were fixed and subjected to
morphometric analysis. Intima/media ratios (I/M%) expressed as degree of
myointimal proliferative response to vascular injury were (means ± SEM):
ducible. Rat aortic SMC were plated at a 1:3 split ratio in 1% fetal bovine
serum (FBS), and made quiescent 24 hr later by changing the medium to 1%
control process serum replacement II. Cells were stimulated with PDGF (2
ng/ml), and at the same time, oligonucleotides were added. Cell proliferation
was determined by measuring 3H-Thymidine uptake at 18-22 hr. To compare
the specificity olthe antiproliferative effects. 20 J.LM of AS c-myb and several
control oligos were used. These included (Batch A): 18-mer sense (5) c-myb.
19-mer mouse antisense and four-base mismatch AS to Il-l,8, and 18- and
16-mer human AS to CML. To determine the reproducibility of the AS ef-
fect, the same 18-mer AS c-myb and scrambled (Sc) lS-mer from another
source (B) were used under exactly the same conditions. To further evaluate
the reproducibility of the AS effect, two different preparations (Batch C) of
the same 18-mer AS and S c-myb from the initial manufacturer were tested
under exactly the same culture conditions.
Conclusions: This study shows: 1) that antisense oligonucleotides pro-
duce a non-specific in-vitro antiproliferative effect and 2) the in-vitro results
may vary with respect to source and batches of oligonucleotides. The lack of
consistency in results raises significant questions about clinical therapeutic
potential.
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In Vivo Incorporation Kinetics of 35S Labelled
Antisense c-myc Oligonucleotides in Rabbits
Carotid Arteries
In Vitro Antiproliferative Effect of Antisense
Oligonucleotides: Are the Effects Specific and
Reproducible?
Genetic Modification of Atherosclerotic Arteries
Following Balloon Angioplasty
Mark J. Pirwitz. Charles landau, Maureen A. Willard, Robert O. Gerard, Robert
S. Meidell, John E. Willard. University of Texas Southwestern Medical Cente" Dallas,
Texas
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Angelica Fieser, Patrick Rabbath, Martin Bouchard, Remi Martel, Pierre Voisine,
Guy leclerc. University ofMontreal School of Medecine, Notre-Dame Hospital,
Montreal, PO, Canada
Antisense oligonucleotides oligonucleotides complementary to c-myc
mRNA inhibit smooth muscle cell proliferation in vitro and may reduce the
proliferative response to vascular injury in vivo following balloon angioplasty.
The purpose of this study was to evaluate the in vivo incorporation kinetics
of 35S labelled phosphorothioate antisense c-myc oligonucleotides by as-
sessing the effect of transfection time, of lipofectin or Iipofectamin on tis-
sue penetration and retention following transfection in the carotid artery. A
total of 117 New Zealand white rabbit carotid arteries were transfected with
80 J.LM of c-myc antisense oligonucleotide in a 1 cm portion either alone
(n = 37) or in combination with lipofectin (100 /Lg/ml or 500 /Lg/ml) (n =
50) or lipofectamin (100 /Lg/ml or 500 /Lg/ml) (n = 30) for periods of either
15,30,60, 120 or 240 minutes. Radiolabelled oligonucleotide incorporation
level was evaluated by automated scintillation counting and tissue localisa-
tion by dot counting following radiographic emulsion exposure of histolog-
ical sections. Retention evaluation was performed at 24, 48 and 72 hours
post-transfection. A high correlation factor (r2 = 0.96) was obtained between
the two evaluation methods. Maximal incorporation was seen after 15 min
exposure (7.84% ± 1.59%, P < 0.05 vs other groups). Maximal radioactivity
retained was found at 24 hours (0.743% incorporation ± 0.096%), decreas-
ing rapidly thereafter (0.57% at 48 hours and 0.247% at 72 hours, p < 0.05).
Efficiency of transfection was not increased by lipofectin or lipofectamin. la-
belled oligonucleotide were located mainly in the media (3.85E + 07 dots ±
5.85E + 06 dots) and significantly less in the adventia (7.55E + 06 dots ±
1.84E + 06 dots). Conclusions: l-In vivo vascular transfection of phospho-
rothioate oligonucleotides, without specific vectors, results in good medial
tissue penetration, with however a low retention level after 24 hours. 2- This
transfer modality does not appear to be enhaced with the use of Iiposomes.
Genetic modification of the vessel wall by catheter-based techniques of-
fers great potential in the treatment of atherosclerotic vascular disease. This
study was therefore undertaken to characterize the response of atheroscle-
rotic vessels exposed to adenoviral vectors following balloon angioplasty.
Atherosclerotic lesions were created in iliac arteries of NZW rabbits by en-
dothelial denudation. After 4-6 weeks on a 1.5% cholesterol diet, balloon
angioplasty was performed at the site of maximal stenosis detected by iliac
angiography. Recombinant adenovirus encoding a nuclear-localizing variant
of E. coli ,8-galactosidase (,8Gal) was then delivered to the vessels by 1 of
4 techniques: a double balloon catheter (n = 7), a Hydrogel-coated balloon
catheter (n = 3), a perforated balloon infusion catheter (n = 3), or a Dispatch
catheter (n = 4). Four days after infection, sections of the modified vessels
were harvested and stained with X-gal solution. Eosin-counterstained sec-
tions were examined forthe presence and location of ,8Gal activity. Success-
ful gene transfer was observed in all sections displaying evidence of balloon-
induced barotrauma, manifested primarily by arterial dissection, regardless
of the device used. Genetically modified cells were located in pockets within
the intima, media, and adventitia bordering dissection planes, or in areas ad-
jacent to defects in the internal elastic membrane. To a lesser degree, cells
expressing ,8Gal were found in peri luminal regions of the intact intima. Ex-
tensive transmural or circumferential diffusion of the vector was not seen.
In conclusion, gene transfer to an atherosclerotic vessel subjected to bal-
loon angioplasty is feasible with recombinant adenovirus vectors and cur-
rently available delivery catheters. The regions of the vessel wall which ex-
press the foreign protein are those which contribute to the proliferative cel-
lular response which characterizes post-angioplasty restenosis.
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The involvement of proto-oncogenes in cell proliferation is well documented.
One of these, the oncogene c-myb is a DNA-binding protein that regulates
cell growth and differentiation. In-vitro studies have shown marked inhibi-
tion of smooth muscle cell (SMC) proliferation using antisense (AS) c-myb
oligonucleotides. The purpose of this study was to determine whether the
in-vitro antiproliferative effect of AS oligonucleotides is specific and repro-
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The loss index (late loss/acute gain) was identical in the 3 groups. In con-
clusion, in this quantitative study, the deletion polymorphism of the ACE
gene did not influence the occurence of restenosis after PTCA.
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Long Term Outcome of
Mono-Immunosuppression in Cardiac Transplant
Recipients
~
eJ
til
'"eJ\.0
()
.5 .25
.~n
~
..
-25 u
..
Right Ventricular Ejection Fraction is Superior to
MV02 in Predicting Event-free Survival in
Advanced Heart Failure
Thomas Di Salvo, Michael Mathier, Dennis McNamara, Marc Semigran, G.
William Dec. Massachusetts General Hospital and Harvard Medical School, Boston, MA
Jon A. Kobashigawa, Michael P. Gleeson, Hillel Laks, Jaime Moriguchi,
Nobuyuki Kawata, Michele Hamilton, Antoine Hage, Davis Drinkwater. UCLA
Medical Center, Los Angeles, CA
Steroid-free immunosuppression has been reported to be successful in se-
lect cardiac transplant recipients. Further reduction of immuno-suppression
meditation (using cyclosporine alone) has been reported; however, there is
concern regarding long term outcome. In our institution, since 1989, 16 car-
diac transplant patients on double-immunosuppression (cyclosporine and
azathioprine) whose WBC decreased to less than 4,000 were also taken
off azathioprine and maintained on mono-immunosuppression (cyclosporine
alone). Five year actuarial survival for this group is 92%, and there has been
no evidence for transplant coronary artery disease (defined as any luminal
irregularity) in any of the annual coronary angiograms. Comparison of actu-
arial survival curves between mono-immunosuppression patients and triple-
immunosuppression patients is as follows:
Cardiac Transplant: Mechanics and the
Peri·Transplant Period
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Functional capacity assessed by maximum oxygen consumption (MV02)
and percent age-sex adjusted MV02 achieved (% MV02) predicts survival
in heart failure (HF). To determine the exercise parameters which best pre-
dict survival, 66 patients with advanced HF (mean age 51 ± 9.9 mean ± SO;
58% NYHA III, 18% NYHA IV; mean LVEF 0.22 ± 0.07) underwent simultane-
ous cardiopulmonary exercise testing and first-pass rest/exercise radionu-
c1ide ventriculography during transplant (TX) evaluation. Mean MV02 was
11.8 ± 4.2 mllkg/min, mean % MV02 38 ± 11.9%. During median follow-
up 93 weeks, 16/66 patients (25%) died. Univariate predictors of survival
included restRVEF > 0.35, exRVEF > 0.35, and % MV02 > 45% (all p <
0.05). In a multivariate proportional hazards survival model, exRVEF > 0.35
(p < 0.01) and % MV02 > 45% (p = 0.01) were selected as predictors. 28/66
patients (42%) reached the combined end-point of death or hospitalization
for inotropic/mechanical bridging (IN) to cardiac TX. Univariate predictors of
IN-free survival included restRVEF > 0.35 (p = 0.01), exRVEF > 0.35 (p <
0.01). NYHAC (p < 0.05), mid % MV02 > 45% (p = 0.05). exRVEF > 0.35
(p = 0.01) was the only predictor of IN-free survival selected in a multivari-
ate proportional hazards model. MV02, CI rest/exercise, LVEF rest/exercise,
exercise-related rise or fall> 0.05 in LVEF or RVEF were not predictive of sur-
vival or IN-free survival in any univariate or multivariate analysis. Conclusions:
1) RVEF > 0.35 at rest and exercise is a more potent predictor of survival in
advanced HF than MV02 or % MV02; 2) % MV02 but not MV02predicts
survival in advanced HF; 3) neither % MV02 nor MV02predict survival to the
combined end-point death or admission for inotropic or mechanical support.
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Cytomegalovirus Infection Increases Neointimal
Formation in the Rat Model of Balloon Injury
Yi Fu Zhou, Matie Shou, Raul Guzman, Esther Guetta, Toren Finkel, Stephen
E. Epstein. National Institutes of Health, Bethesda, MD
Does Insertion/Deletion Polymorphism of the
Angiotensin Converting Enzyme Influence the
Occurence of Restenosis After Percutaneous
Transluminal Coronary Angioplasty?
Martial Hamon 1, Christophe Bauters 1, Carole Amant 2, Eugene Mc Fadden 1,
Nicole Helbeque 2, Jean-Marc Lablanche 1, Michel Bertrand 1, Philippe Amouyel 2.
1 University and CHRU de lille; 2 Institut Pasteur de lille
Conclusion: These data indicate that the gender difference in myointimal
proliferation after vascular injury is estrogen dependent. These findings have
direct implications for the prevention and treatment of vascular disease in
human subjects.
Previous studies have suggested that cytomegalovirus (CMV) infection may
playa role in the development of atherosclerosis. A recent study we con-
ducted in patients who developed restenosis following coronary angio-
plasty suggested that the presence of CMY. an extremely common human
pathogen, was a possible contributing cause of restenosis. To determine
whether CMV can increase injury-induced neointimal formation in an ani-
mal model, we measured the neointimal response to injury of the rat carotid
artery following rat CMV (RCMV) infection. Standard left carotid balloon in-
jury was performed on thirty male Spraque-Oawley rats (400-450 g). One day
after injury, fifteen olthe balloon injured rats received an intraperitoneal injec-
tion of approximately 106 active viral particles/ml of RCMV (Priscott strain),
while another fifteen control rats received an intraperitoneal injection of nor-
mal saline. Six weeks later, the salivary glands, spleen and left carotid arteries
were harvested. To assay for the presence of replicating virus, serial dilution
of tissue homogenates were used to inoculate a monolayer of permissive
indicator cells (rat embryonic fibroblast) and the presence or absence of cy-
topathic effect was determined. In infected animals, infectious viral parti-
cles could routinely be recovered from both salivary glands and spleen, but
only occasionally from vascular tissues. Assessment of the neointimal to me-
dial (N/M) ratio by computerized image analyzer revealed that the neointimal
thickness of RCMV infected animals was nearly 40% greater than that of
control animals (N/M ratio 1.62 ± 0.56 vs 1.17 ± 0.61; P < 0.05).
Conclusion: RCMV infection of immunocompetent adult rats increases the
neointimal response to vascular injury. This finding provides further evidence
suggesting that CMV may playa crucial role in the development of restenosis
in patients undergoing angioplasty.
The insertion/deletion (I/O) polymorphism of the angiotensin converting en-
zyme (ACE) is related to the pathogenesis of coronary artery disease. The
deletion allele is strongly associated with the level of circulating ACE and is a
potent risk factor for myocardial infarction (MI). Recently, the deletion allele
was also associated with the occurrence of visually diagnosed restenosis
after percutaneous transluminal coronary angioplasty (PTCAI in a selected
population of patients with acute MI.
We investigated the influence of the ACE 110 polymorphism on the oc-
currence of restenosis after PTCA, using quantitative coronary angiography.
ACE lID genotypes were analysed in 118 consecutive patients with one ves-
sel disease. All of them underwent PTCA and had a systematic angiographic
follow-up (Fup). Coronary angiograms were analysed before and after PTCA,
and at Fup (7.5 ± 3 months).
Before PTCA, no clinical or angiographic differences were detected be-
tween the three groups of genotypes. At Fup, the absolute minimal lumen
diameter and percent stenosis were similar in the 3 groups of genotypes.
Acute gain (mm)
Late loss (mm)
Stenosis> 50% (Fup)
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Conclusion: Mono-immunosuppression (cyclosporine alone) appears suc-
cessful in select cardiac transplant recipients. The low risk for transplant
coronary artery disease may be due to a lowering of associated risk factors
and the selection of an "immuno-privileged" patient population.
